Ilan Daskal - Net Worth and Insider Trading

Ilan Daskal Net Worth

The estimated net worth of Ilan Daskal is at least $287,640 dollars as of 2024-04-23. Ilan Daskal is the Director of Natus Medical Inc and owns about 8,648 shares of Natus Medical Inc (NTUS) stock worth over $285,038. Ilan Daskal is also the EVP, CFO of Bio-Rad Laboratories Inc and owns about 9 shares of Bio-Rad Laboratories Inc (BIO) stock worth over $2,602. Details can be seen in Ilan Daskal's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ilan Daskal has not made any transactions after 2021-09-03 and currently still holds the listed stock(s).

Transaction Summary of Ilan Daskal

Ilan Daskal Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ilan Daskal owns 7 companies in total, including Bio-Rad Laboratories Inc (BIO) , Natus Medical Inc (NTUS) , and Ixia (XXIA) among others .

Click here to see the complete history of Ilan Daskal’s form 4 insider trades.

Insider Ownership Summary of Ilan Daskal

Ticker	Comapny	Transaction Date	Type of Owner
BIO	Bio-Rad Laboratories Inc	2021-04-08	EVP & Chief Financial Officer
NTUS	Natus Medical Inc	2021-06-11	director
XXIA	Ixia	2017-04-18	director
SDSNQ.PFD	SunEdison Inc	2016-04-08	EVP & CFO Designee
TERP	TerraForm Power Inc	2016-03-30	director
GLBL	TerraForm Global Inc	2016-03-30	director
CPHD	Cepheid	2015-04-09	EVP & Chief Financial Officer

Ilan Daskal Latest Holdings Summary

Ilan Daskal currently owns a total of 2 stocks. Among these stocks, Ilan Daskal owns 8,648 shares of Natus Medical Inc (NTUS) as of June 11, 2021, with a value of $285,038 and a weighting of 99.1%. Ilan Daskal also owns 9 shares of Bio-Rad Laboratories Inc (BIO) as of September 3, 2021, with a value of $2,602 and a weighting of 0.9%.

Latest Holdings of Ilan Daskal

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
NTUS	Natus Medical Inc	2021-06-11	8,648	32.96	285,038
BIO	Bio-Rad Laboratories Inc	2021-09-03	9	289.10	2,602

Holding Weightings of Ilan Daskal

Ilan Daskal Form 4 Trading Tracker

According to the SEC Form 4 filings, Ilan Daskal has made a total of 1 transactions in Natus Medical Inc (NTUS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Natus Medical Inc is the sale of 2,500 shares on June 11, 2021, which brought Ilan Daskal around $68,650.

According to the SEC Form 4 filings, Ilan Daskal has made a total of 3 transactions in Bio-Rad Laboratories Inc (BIO) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Bio-Rad Laboratories Inc is the sale of 270 shares on September 3, 2021, which brought Ilan Daskal around $221,416.

Insider Trading History of Ilan Daskal

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ilan Daskal Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ilan Daskal Ownership Network

Ownership Network List of Ilan Daskal

No Data

Ownership Network Relation of Ilan Daskal

Ilan Daskal Owned Company Details

What does Bio-Rad Laboratories Inc do?

Who are the key executives at Bio-Rad Laboratories Inc?

Ilan Daskal is the EVP & Chief Financial Officer of Bio-Rad Laboratories Inc. Other key executives at Bio-Rad Laboratories Inc include INT PRIN ACCTG OFC Tania Devilliers , EVP & Global Supply Chain Sedat Evran , and EVP & Global Human Resources Corey Colleen .

Bio-Rad Laboratories Inc (BIO) Insider Trades Summary

Over the past 18 months, Ilan Daskal made no insider transaction in Bio-Rad Laboratories Inc (BIO). Other recent insider transactions involving Bio-Rad Laboratories Inc (BIO) include a net sale of 6,896 shares made by Timothy S Ernst , a net sale of 3,642 shares made by Michael Crowley , and a net sale of 577 shares made by Ajit Ramalingam .

In summary, during the past 3 months, insiders sold 5,500 shares of Bio-Rad Laboratories Inc (BIO) in total and bought 0 shares, with a net sale of 5,500 shares. During the past 18 months, 12,315 shares of Bio-Rad Laboratories Inc (BIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 12,315 shares.

Bio-Rad Laboratories Inc (BIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Bio-Rad Laboratories Inc Insider Transactions

No Available Data

What does Natus Medical Inc do?

Who are the key executives at Natus Medical Inc?

Ilan Daskal is the director of Natus Medical Inc. Other key executives at Natus Medical Inc include Vice President Medical Affairs Chung Dong Chune Christopher , director & Sr. VP & CFO Jonathan Kennedy , and VP/GM Neurology Noll Austin Francis Iii .

Natus Medical Inc (NTUS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Natus Medical Inc (NTUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Natus Medical Inc (NTUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Natus Medical Inc (NTUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Natus Medical Inc Insider Transactions

No Available Data

What does Ixia do?

Who are the key executives at Ixia?

Ilan Daskal is the director of Ixia. Other key executives at Ixia include director & President and CEO Bethany Mayer , Chief Financial Officer Brent T Novak , and Sr. Vice President & Operations Graaf Raymond De .

Ixia (XXIA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ixia (XXIA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ixia (XXIA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ixia (XXIA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ixia Insider Transactions

No Available Data

What does SunEdison Inc do?

Who are the key executives at SunEdison Inc?

Ilan Daskal is the EVP & CFO Designee of SunEdison Inc. Other key executives at SunEdison Inc include 10 percent owner Svp Special Situations Iv Llc , 10 percent owner Svp Special Situations Iii-a Llc , and 10 percent owner Svp Special Situations Iii Llc .

SunEdison Inc (SDSNQ.PFD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of SunEdison Inc (SDSNQ.PFD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SunEdison Inc (SDSNQ.PFD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

SunEdison Inc (SDSNQ.PFD)'s detailed insider trading history can be found in Insider Trading Tracker table.

SunEdison Inc Insider Transactions

No Available Data

What does TerraForm Power Inc do?

Who are the key executives at TerraForm Power Inc?

Ilan Daskal is the director of TerraForm Power Inc. Other key executives at TerraForm Power Inc include 10 percent owner Brookfield Asset Management Private Institutional Capital Adviser (canada) Lp , 10 percent owner Partners Ltd , and 10 percent owner Brookfield Asset Management Inc. .

TerraForm Power Inc (TERP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of TerraForm Power Inc (TERP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TerraForm Power Inc (TERP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TerraForm Power Inc (TERP)'s detailed insider trading history can be found in Insider Trading Tracker table.

TerraForm Power Inc Insider Transactions

No Available Data

What does TerraForm Global Inc do?

Who are the key executives at TerraForm Global Inc?

Ilan Daskal is the director of TerraForm Global Inc. Other key executives at TerraForm Global Inc include 10 percent owner Brookfield Asset Management Inc. , 10 percent owner Brookfield Asset Management Private Institutional Capital Adviser (canada) Lp , and 10 percent owner Partners Ltd .

TerraForm Global Inc (GLBL) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of TerraForm Global Inc (GLBL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TerraForm Global Inc (GLBL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TerraForm Global Inc (GLBL)'s detailed insider trading history can be found in Insider Trading Tracker table.

TerraForm Global Inc Insider Transactions

No Available Data

What does Cepheid do?

Who are the key executives at Cepheid?

Ilan Daskal is the EVP & Chief Financial Officer of Cepheid. Other key executives at Cepheid include director & Chairman of the Board and CEO John L Bishop , EVP & Global Ops & Engineering Marc Haugen , and EVP & CFO Andrew Miller .

Cepheid (CPHD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cepheid (CPHD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cepheid (CPHD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cepheid (CPHD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cepheid Insider Transactions

No Available Data

Ilan Daskal Mailing Address

Above is the net worth, insider trading, and ownership report for Ilan Daskal. You might contact Ilan Daskal via mailing address: 1000 Alfred Nobel Drive, Hercules Ca 94547.

Discussions on Ilan Daskal

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.